Greenwich Lifesciences Inc
NASDAQ:GLSI
Greenwich Lifesciences Inc
NASDAQ:GLSI
Price:
25.78
USD
-0.15%
Market Closed
Market Cap:
$357.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Greenwich Lifesciences Inc
NASDAQ:GLSI
|
US |
|
ICF International Inc
NASDAQ:ICFI
|
US |
|
Shan Dong Lubei Chemical Co Ltd
SSE:600727
|
CN |
|
S
|
Seng Fong Holdings Bhd
KLSE:SENFONG
|
MY |
|
D.I. System Co Ltd
TSE:4421
|
JP |
|
Jiangsu King's Luck Brewery Joint-Stock Co Ltd
SSE:603369
|
CN |
|
Edreams Odigeo SA
MAD:EDR
|
ES |
|
New Talisman Gold Mines Ltd
NZX:NTL
|
NZ |
|
H
|
Horizonte Minerals PLC
TSX:HZM
|
UK |
|
Applied Minerals Inc
OTC:AMNL
|
US |
|
Nihon Shokuhin Kako Co Ltd
TSE:2892
|
JP |
|
C
|
China Everbright Ltd
HKEX:165
|
HK |
|
S
|
Shanghai Smart Control Co Ltd
SZSE:001266
|
CN |
|
Parag Milk Foods Ltd
NSE:PARAGMILK
|
IN |
|
Trelleborg AB
STO:TREL B
|
SE |
|
A
|
ALD SA
PAR:ALD
|
FR |
|
J
|
Jiangsu Hongdou Industrial Co Ltd
SSE:600400
|
CN |
|
C
|
Clicks Group Ltd
JSE:CLS
|
ZA |
|
Klea Holding
PAR:ALKLH
|
FR |
|
Puravankara Ltd
NSE:PURVA
|
IN |
|
A
|
Assam Entrade Ltd
BSE:542911
|
IN |
|
Shanghai Medicilon Inc
SSE:688202
|
CN |
|
Straker Translations Ltd
ASX:STG
|
NZ |
|
Agilysys Inc
NASDAQ:AGYS
|
US |
Balance Sheet
Balance Sheet Decomposition
Greenwich Lifesciences Inc
Greenwich Lifesciences Inc
Balance Sheet Decomposition is not available for
Greenwich Lifesciences Inc
Greenwich Lifesciences Inc
Balance Sheet
Greenwich Lifesciences Inc
Greenwich Lifesciences Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
29
|
27
|
13
|
7
|
4
|
|
| Cash |
0
|
0
|
0
|
29
|
27
|
13
|
7
|
4
|
|
| Total Current Assets |
0
|
0
|
0
|
29
|
27
|
13
|
7
|
4
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
0
+267%
|
0
-73%
|
29
+95 500%
|
27
-5%
|
13
-50%
|
7
-48%
|
4
-41%
|
|
| Liabilities | |||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
1
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
2
|
|
| Long-Term Debt |
8
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
9
N/A
|
10
+20%
|
1
-87%
|
1
-24%
|
0
-63%
|
0
-33%
|
0
+13%
|
2
+430%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
22
|
24
|
27
|
29
|
34
|
41
|
50
|
66
|
|
| Additional Paid In Capital |
14
|
14
|
26
|
57
|
60
|
55
|
57
|
69
|
|
| Total Equity |
9
N/A
|
10
-19%
|
1
+87%
|
28
N/A
|
27
-3%
|
13
-51%
|
7
-49%
|
3
-62%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
+267%
|
0
-73%
|
29
+95 500%
|
27
-5%
|
13
-50%
|
7
-48%
|
4
-41%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
12
|
12
|
12
|
13
|
13
|
13
|
13
|
13
|
|
Switch to:
Switch to:
See Also
Discover More
